Delta Investment Management LLC Buys Shares of 20,548 LHC Group, Inc. (LHCG)

Delta Investment Management LLC bought a new position in LHC Group, Inc. (NASDAQ:LHCG) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 20,548 shares of the health services provider’s stock, valued at approximately $2,277,000. LHC Group makes up 2.0% of Delta Investment Management LLC’s portfolio, making the stock its 26th biggest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Parallel Advisors LLC lifted its holdings in LHC Group by 790.0% during the 1st quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after buying an additional 237 shares in the last quarter. Sageworth Trust Co acquired a new position in LHC Group during the 1st quarter worth $36,000. Financial Gravity Companies Inc. acquired a new position in LHC Group during the 4th quarter worth $49,000. Quadrant Capital Group LLC lifted its holdings in LHC Group by 1,045.7% during the 1st quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after buying an additional 481 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in LHC Group during the 1st quarter worth $68,000. 94.07% of the stock is currently owned by institutional investors and hedge funds.

Shares of LHC Group stock traded up $0.27 on Wednesday, hitting $115.66. 1,601 shares of the company’s stock traded hands, compared to its average volume of 291,507. The stock has a market capitalization of $3.59 billion, a price-to-earnings ratio of 32.63, a PEG ratio of 1.94 and a beta of 0.87. LHC Group, Inc. has a one year low of $73.00 and a one year high of $116.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.90 by $0.08. The company had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. As a group, research analysts forecast that LHC Group, Inc. will post 4.3 EPS for the current fiscal year.

In related news, CEO Keith G. Myers sold 75,000 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $108.53, for a total value of $8,139,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Donald Dwayne Stelly sold 15,151 shares of the company’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $107.06, for a total transaction of $1,622,066.06. Following the completion of the sale, the chief operating officer now owns 92,065 shares of the company’s stock, valued at approximately $9,856,478.90. The disclosure for this sale can be found here. Insiders have sold a total of 117,876 shares of company stock valued at $12,762,540 in the last quarter. Corporate insiders own 5.20% of the company’s stock.

Several research analysts have issued reports on LHCG shares. BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 28th. Craig Hallum upped their price objective on LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a report on Friday, March 1st. They noted that the move was a valuation call. SunTrust Banks upped their target price on shares of LHC Group to $130.00 and gave the company a “buy” rating in a research report on Friday, March 1st. Robert W. Baird upped their target price on shares of LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Finally, Barclays upped their target price on shares of LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Thursday, March 21st. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $118.50.

TRADEMARK VIOLATION NOTICE: “Delta Investment Management LLC Buys Shares of 20,548 LHC Group, Inc. (LHCG)” was first posted by WKRB News and is owned by of WKRB News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.wkrb13.com/2019/05/15/delta-investment-management-llc-buys-shares-of-20548-lhc-group-inc-lhcg.html.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: Quick Ratio

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.